How Is Baldness Passed Down? The Genetics Explained

Understand the intricate genetic processes behind hair loss. This article details how various genes and inheritance patterns influence the transmission of baldness.

Baldness runs in families, and roughly 80% of the variation in whether and when a man loses his hair comes down to genetics. The single most influential gene sits on the X chromosome, which sons inherit exclusively from their mothers, giving rise to the old saying that you should look at your mother’s father to predict your own hairline. That advice is not wrong, but it is incomplete. Genome-wide studies have now identified well over a hundred genetic regions spread across nearly every chromosome that contribute to hair loss, making the full picture far more tangled than any one parent’s head of hair can reveal.

The X Chromosome and Your Mother’s Side

The gene that gets the most attention in baldness research is the androgen receptor gene, known as AR, located on the X chromosome. A landmark genetic study found that variation in this gene is “the cardinal prerequisite” for early-onset male pattern baldness, with an estimated contribution of about 46% to developing the condition early in life. Earlier work had already linked a specific restriction site in the AR gene to baldness, finding it in about 98% of young bald men compared with roughly 77% of men who were not bald.

Because the AR gene lives on the X chromosome, men get exactly one copy, and it always comes from Mom. That is why the maternal grandfather’s hair (or lack of it) became folk wisdom for predicting a man’s future. A balding maternal grandfather likely passed the relevant AR variant to the mother, who then had a 50/50 chance of passing it along to each of her sons. The science confirms the intuition: a predisposition inherited from a mother carries more weight than one inherited from a father.

Your Father’s Genes Matter Too

If the X chromosome told the whole story, two brothers with the same mother would always share the same baldness fate. They often do not. That is because the AR gene, while the single strongest contributor, is far from the only one. A large genome-wide study using UK Biobank data found 112 baldness-associated genes on the autosomes (the non-sex chromosomes that both parents contribute) alongside 13 on the X chromosome. Even in that analysis, AR remained the top hit, but the sheer number of autosomal genes underscores how much of the picture comes from both sides of the family.

A separate genomic heritability analysis put hard numbers on the split: about 82% of the genetic contribution to baldness comes from autosomes, while only around 12% comes from the X chromosome. That means your father’s DNA matters a great deal, even though no single gene on his side packs the same punch as AR. The risk accumulates: the more affected relatives you have on either side, the higher your own chances, and the distribution of balding patterns across the general population follows a smooth bell curve rather than the sharp all-or-nothing pattern you would expect from a single gene.

How High Is Heritability, Really?

A twin study comparing nearly 900 pairs of identical and fraternal male twins aged 25 to 36 found a heritability of 81%, meaning that the vast majority of person-to-person differences in hair loss progression are genetic rather than environmental. The remaining roughly 20% leaves room for factors like stress, nutrition, and lifestyle, but genes clearly dominate. Identical twins, who share all their DNA, showed strikingly similar balding patterns, whereas fraternal twins diverged noticeably more.

An important caveat: heritability does not mean destiny for any one person. It describes how much of the variation across a population is genetic. You can carry many risk variants and still keep a full head of hair into middle age if the combinatorics happen to work in your favor, or if environmental conditions are different from those that shaped the study population.

What the Genes Actually Do to Your Hair

The biological endpoint of all these genetic risk factors is a hormone-driven process called follicle miniaturization. Testosterone is converted into a more potent form called dihydrotestosterone (DHT), and hair follicles on the crown and temples of genetically susceptible people are unusually sensitive to it. DHT progressively shrinks the dermal papilla cells at the base of each follicle, shortening the growth phase of the hair cycle until the follicle produces only fine, nearly invisible vellus hairs instead of thick terminal ones.

Crucially, the follicle does not die. Research comparing bald and haired scalp found that the reservoir of hair follicle stem cells was essentially the same in both. What was missing in bald scalp was a population of progenitor cells that act as the bridge between stem cells and actively growing hair. The stem cells are there, waiting. They just cannot get the signal to produce new, robust hair. That finding has been a cornerstone for researchers trying to develop regenerative treatments: the raw material has not been destroyed, just silenced.

Signaling Pathways That Go Wrong

The genetics of baldness do not all converge on DHT sensitivity. Several signaling pathways that regulate whether hair follicles stay active or go dormant are also involved. Transcriptome profiling of balding versus non-balding scalp tissue has revealed changes in the Wnt/β-catenin pathway, which is one of the central signals telling a follicle to grow, along with alterations in the HIF-1 pathway, which is related to oxygen sensing. The gene APCDD1, for instance, suppresses Wnt signaling upstream of a key growth-promoting protein, effectively putting the brakes on hair cycling.

On the prostaglandin side, balding scalp shows elevated levels of certain prostaglandins that inhibit hair growth and reduced levels of others that promote it. Specifically, prostaglandin D2 is higher in bald areas while prostaglandin E2 and F2α are lower. These lipid signals may explain why the balding process is so localized: follicles on the sides and back of the head, even in the same person, are bathed in a different chemical microenvironment. Inflammation also plays a part. Bald and thinning follicles tend to be surrounded by infiltrates of immune cells, and inflammatory genes are more active in affected tissue.

Mitochondrial Stress in Balding Follicles

An emerging line of research points to the energy factories inside cells. Dermal papilla cells taken from balding scalp show compromised mitochondrial function: reduced activity in key parts of the energy production chain, lower levels of the cell’s energy currency (ATP), and significantly higher oxidative stress compared with non-balding tissue from the same individuals. Experiments applying antioxidants to these cells lowered oxidative stress and improved metabolite uptake, hinting at a possible therapeutic angle, though this remains laboratory work rather than a proven treatment.

Epigenetic Twists

Genes are not the only layer of inherited information. Epigenetic modifications, which change how actively a gene is read without altering the DNA sequence itself, also differ between balding and non-balding scalp. The androgen receptor gene shows higher DNA methylation in occipital (back-of-head) follicles, the region resistant to hair loss, compared with vertex (crown) follicles, where hair loss concentrates. Methylation in gene-control regions typically dials down expression, so the pattern fits: the back of the head may resist DHT partly because the androgen receptor is being epigenetically muffled there. This also helps explain why transplanted hairs from the back of the head keep growing after being moved to the crown. They carry their epigenetic instructions with them.

Why Female Hair Loss Is a Different Genetic Story

Women experience pattern hair loss too, typically as diffuse thinning across the top of the scalp rather than a receding hairline or bald crown. Despite the superficial similarity, the genetic architecture appears substantially different. The risk genes identified in men do not account for the pattern seen in women, pointing to distinct genetic pathways. Women’s genetic studies remain underpowered compared with the massive male cohorts that have driven most discoveries, so the specific genes involved are still being mapped. What is clear is that a family history of female hair loss in your mother or grandmother does not predict male-pattern baldness in the same straightforward way that the maternal grandfather’s hairline does, because the underlying genetic contributors overlap only partially.

Can Genetic Tests Predict Your Future Hairline?

Consumer genetic tests sometimes claim to predict baldness risk, and researchers have built polygenic scores that combine the effects of many variants at once. The honest state of the science is that these scores are still limited. One early polygenic score analysis found that the combined effect of known variants explained only about 1.4 to 4.5% of the variance in baldness between individuals. A later, much larger study pushed that to 38% of total heritability using 107 significant genetic markers, but that still leaves more than half the genetic contribution unexplained.

A further complication: most of these genetic discoveries come from European-ancestry populations. When applied to people of African descent, the same polygenic scores perform poorly, and the underlying genetic architecture of baldness appears to differ between continental groups. This is not because baldness works differently at a biological level but because different populations carry different sets of common variants that contribute to risk. Research examining this gap found that the differences were shaped more by neutral evolution (random genetic drift over millennia) than by natural selection actively favoring or disfavoring baldness in specific environments. The practical takeaway: a genetic baldness test calibrated on one ancestry group may be misleading for someone from another background.

Pharmacogenomics and Treatment Response

If genetics determines who goes bald, it also influences who responds to treatment. Pharmacogenomic work has linked variants in genes involved in how the body activates minoxidil, how it processes the enzyme that converts testosterone to DHT, and how it synthesizes prostaglandins to differences in treatment outcomes. In plain terms, two people with the same degree of hair loss may respond very differently to the same drug because their genetic backgrounds affect how efficiently they metabolize it. This field is still young, and no test yet reliably tells a patient which treatment will work best for them, but the direction is toward more personalized prescribing.

Why Has Evolution Not Eliminated Baldness?

Given that baldness genes are so common and heritable, evolutionary biologists have puzzled over why natural selection has not weeded them out. Several hypotheses exist. One proposes that baldness served as a visible age signal, helping women in ancestral populations select younger mates. Since children fathered by younger men tend to have better health outcomes, this “selfless gene” idea suggests baldness could have indirectly benefited the broader population even at a cost to the individual who went bald.

Other frameworks include antagonistic pleiotropy, in which variants that help with reproduction early in life have downsides that show up later, and genetic hitchhiking, where baldness-linked variants sit close to other variants that were positively selected on the X chromosome. The study of African populations mentioned earlier found no evidence that Neanderthal DNA introgression drove continental differences in baldness genetics, and little evidence for strong natural selection on baldness loci in general. The most likely explanation is that baldness is not harmful enough to survival or reproduction to create strong selective pressure against it. It persists largely because evolution has no particular reason to eliminate it.

Clock Genes and Hair Cycling

One unexpected finding in hair biology is the involvement of circadian clock genes, the same molecular machinery that governs your sleep-wake cycle. Research has shown that these genes help regulate the hair growth cycle, influencing when follicles transition between active growth, regression, and rest phases. The hair cycle operates over weeks to years rather than hours, so the connection between a 24-hour clock and a months-long biological rhythm was surprising. How this intersects with baldness genetics is not fully worked out, but it raises the possibility that disruptions to circadian rhythms, whether from shift work, chronic sleep deprivation, or aging, could interact with genetic susceptibility to accelerate hair loss. Research into this link is still in early stages, and no one should interpret it as proof that sleeping better will prevent baldness. But it does reveal that the biology of hair loss reaches into corners of cellular regulation that nobody expected when the first androgen receptor variants were identified decades ago.